Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 46, 2012, Pages 18903-18908

  Zhu, Xueyong ^a   Yang, Hua ^b   Guo, Zhu ^b   Yu, Wenli ^a   Carney, Paul J ^b   Li, Yan ^b   Chen, Li Mei ^b   Paulson, James C ^a   Donis, Ruben O ^b   Tong, Suxiang ^b   Stevens, James ^b   Wilson, Ian A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Enzyme; Glycoprotein; Infection; Mechanism; Receptor

Indexed keywords

MONOMER; N10 NEURAMINIDASE LIKE PROTEIN; SIALIDASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BAT; CALCIUM BINDING; CRYSTAL STRUCTURE; ENZYME ACTIVITY; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE;

ANIMALS; CATALYTIC DOMAIN; CHIROPTERA; CRYSTALLOGRAPHY, X-RAY; EVOLUTION, MOLECULAR; INFLUENZA A VIRUS; NEURAMINIDASE; PROTEIN STRUCTURE, SECONDARY; VIRAL PROTEINS;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; STURNIRA LILIUM;

EID: 84869233988     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1212579109     Document Type: Article

References (36)

1. Tong S, et al. (2012) A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci USA 109:4269-4274.
2. Air GM, Laver WG (1989) The neuraminidase of influenza virus. Proteins 6:341-356.
3. Varghese JN, Laver WG, Colman PM (1983) Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution. Nature 303:35-40.
4. Baker AT, Varghese JN, Laver WG, Air GM, Colman PM (1987) Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus. Proteins 2:111-117.
5. Russell RJ, et al. (2006) The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443:45-49.
6. Zhu X, Xu X, Wilson IA (2008) Structure determination of the 1918 H1N1 neuraminidase from a crystal with lattice-translocation defects. Acta Crystallogr D Biol Crystallogr D64:843-850.
7. Wang M, et al. (2011) Influenza A virus N5 neuraminidase has an extended 150-cavity. J Virol 85:8431-8435.
8. Burmeister WP, Ruigrok RW, Cusack S (1992) The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO J 11:49-56.
9. Colman PM, Varghese JN, Laver WG (1983) Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303:41-44.
10. Garman E, Laver G (2005) Viral Membrane Proteins: Structure, Function, and Drug Design, ed Fischer W (Kluwer Academic/Plenum, New York), pp 247-267.
11. Xu X, Zhu X, Dwek RA, Stevens J, Wilson IA (2008) Structural characterization of the 1918 influenza virus H1N1 neuraminidase. J Virol 82:10493-10501.
12. Rudrawar S, et al. (2010) Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase. Nat Commun 1:113.
13. Varghese JN, Colman PM (1991) Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 Å resolution. J Mol Biol 221:473-486.
14. Tulip WR, et al. (1991) Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants. J Mol Biol 221:487-497.
15. Chong AK, Pegg MS, Taylor NR, von Itzstein M (1992) Evidence for a sialosyl cation transition-state complex in the reaction of sialidase from influenza virus. Eur J Biochem 207:335-343.
16. Burmeister WP, Cusack S, Ruigrok RW (1994) Calcium is needed for the thermostability of influenza B virus neuraminidase. J Gen Virol 75:381-388.
17. Smith BJ, et al. (2006) Structure of a calcium-deficient form of influenza virus neuraminidase: Implications for substrate binding. Acta Crystallogr D Biol Crystallogr 62:947-952.
18. Taylor NR, von Itzstein M (1994) Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis. J Med Chem 37:616-624.
19. Janakiraman MN, White CL, Laver WG, Air GM, Luo M (1994) Structure of influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8-Å resolution: Implications for the catalytic mechanism. Biochemistry 33:8172-8179.
20. Gong J, Xu W, Zhang J (2007) Structure and functions of influenza virus neuraminidase. Curr Med Chem 14:113-122.
21. Xu R, et al. (2012) Functional balance of the hemagglutinin and neuraminidase activities accompanies the emergence of the 2009 H1N1 influenza pandemic. J Virol 86:9221-9232.
22. Taylor NR, et al. (1998) Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B. J Med Chem 41:798-807.
23. Eisenberg EJ, Bidgood A, Cundy KC (1997) Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104. Antimicrob Agents Chemother 41:1949-1952.
24. Babu YS, et al. (2000) BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. J Med Chem 43:3482-3486.
25. Yamashita M, et al. (2009) CS-8958, a prodrug of the new neuraminidase inhibitor R- 125489, shows long-acting anti-influenza virus activity. Antimicrob Agents Chemother 53:186-192.
26. Rogers GN, Herrler G, Paulson JC, Klenk HD (1986) Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. J Biol Chem 261:5947-5951.
27. Bartlett GJ, Porter CT, Borkakoti N, Thornton JM (2002) Analysis of catalytic residues in enzyme active sites. J Mol Biol 324:105-121.
28. Lin YP, et al. (2010) Neuraminidase receptor binding variants of human influenza A (H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: A role in virus attachment? J Virol 84:6769-6781.
29. Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307-326.
30. McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ (2005) Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr 61:458-464.
31. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53:240-255.
32. Adams PD, et al. (2010) PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213-221.
33. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66:486-501.
34. Esnouf RM (1997) An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J Mol Graph Model 15:132-134, 112-113.
35. Potier M, Mameli L, Bélisle M, Dallaire L, Melançon SB (1979) Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl- alpha-D-N-acetylneuraminate) substrate. Anal Biochem 94:287-296.
36. Chen VB, et al. (2010) MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66:12-21.